AI
RANI icon

Alphabet Inc’s Rani Therapeutics RANI Stock Holding History

Alphabet Inc’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-448,492
Closed -$565K – 39
2025
Q1 		$565K Hold
448,492
– – 0.04% 35
2024
Q4 		$614K Hold
448,492
– – 0.04% 34
2024
Q3 		$969K Hold
448,492
– – 0.05% 35
2024
Q2 		$1.7M Hold
448,492
– – 0.09% 31
2024
Q1 		$1.39M Hold
448,492
– – 0.06% 35
2023
Q4 		$1.49M Hold
448,492
– – 0.07% 33
2023
Q3 		$973K Hold
448,492
– – 0.06% 38
2023
Q2 		$1.85M Hold
448,492
– – 0.1% 34
2023
Q1 		$2.31M Sell
448,492
-61,636
-12% -$371K 0.13% 32
2022
Q4 		$3.01M Sell
510,128
-204,343
-29% -$1.49M 0.17% 31
2022
Q3 		$6.84M Hold
714,471
– – 0.35% 25
2022
Q2 		$7.38M Hold
714,471
– – 0.4% 27
2022
Q1 		$9.64M Buy
+714,471
New +$11.9M 0.31% 31

Other funds holding RANI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alphabet Inc's RANI Position: Q2 2025 in Review

Alphabet Inc sold out of Rani Therapeutics (RANI) in Q2 2025, closing a stake of 448,492 shares — an estimated $565K sold.

Alphabet Inc first reported a position in RANI in Q1 2022 and held it in 13 quarters. The position peaked at $9.64M in Q1 2022. 39 funds tracked by Wall St. Rank hold RANI as of Q2 2025.

  • Alphabet Inc reported no remaining Rani Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Alphabet Inc sold 448,492 Rani Therapeutics shares in Q2 2025, an estimated $565K.
  • Alphabet Inc first reported a position in Rani Therapeutics in Q1 2022 and held it in 13 quarters.
  • Alphabet Inc's Rani Therapeutics position peaked at $9.64M in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2025.

Based on Alphabet Inc's 13F filing for Q2 2025, filed 1 Aug 2025.